Articles

A prospective randomized trial comparing cyclosporine/methotrexate and tacrolimus/sirolimus as graft-versus-host disease prophylaxis after allogeneic hematopoietic stem cell transplantation

Center for Allogeneic Stem Cell Transplantation, Karolinska University Hospital, Stockholm, Sweden;Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden
Center for Allogeneic Stem Cell Transplantation, Karolinska University Hospital, Stockholm, Sweden
Division of Oral and Maxillofacial Surgery, Department of Dental Medicine, Karolinska Institutet, Huddinge, Sweden
Center for Allogeneic Stem Cell Transplantation, Karolinska University Hospital, Stockholm, Sweden;Department of Hematology, Karolinska University Hospital and Division of Hematology, Department of Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
Astrid Lindgren Children’s Hospital, Karolinska University Hospital, Stockholm, Sweden
Department of Internal Medicine, Turku University Hospital, Finland;Turku University, Finland
Department of Internal Medicine, Turku University Hospital, Finland
Center for Allogeneic Stem Cell Transplantation, Karolinska University Hospital, Stockholm, Sweden;Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden
Center for Allogeneic Stem Cell Transplantation, Karolinska University Hospital, Stockholm, Sweden;Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden
Vol. 101 No. 11 (2016): November, 2016 https://doi.org/10.3324/haematol.2016.149294